Home
/

Riboflavin (vitamin B2), decoded

Bill Maish, MD
Clinical Product Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Key takeaway:

Riboflavin converts into the coenzymes FMN and FAD, which drive mitochondrial energy production and recycle the antioxidant glutathione. Functional assays inside red blood cells are more informative than plasma levels, which fluctuate with recent intake. Some research links higher-dose riboflavin to reduced migraine frequency and, in people with the MTHFR 677TT variant, improved blood pressure.

Read more →
Table of contents
```html

Riboflavin, the B vitamin in plain terms

Vitamin B2 is a water-soluble vitamin that your body converts into two coenzymes, FMN and FAD — tiny molecular tools that let hundreds of enzymes function. They power mitochondrial energy production, help burn fats and carbohydrates, and recycle antioxidants like glutathione. When riboflavin status is measured, the most informative tests assess function inside red blood cells rather than the vitamin floating freely in plasma. The erythrocyte glutathione reductase activation coefficient (EGRAC) is one such functional assay: it measures how much a FAD-dependent enzyme responds to added riboflavin, with higher responsiveness indicating that tissues were running short.

The mitochondrial role riboflavin plays in every cell

In mitochondria, FAD and FMN shuttle electrons through the electron transport chain, converting food into ATP. At the same time, riboflavin-dependent enzymes recharge antioxidants that neutralize reactive byproducts — energy production and oxidative protection in a single system.

Riboflavin is also a cofactor for MTHFR, the enzyme central to one-carbon metabolism and homocysteine recycling. In some studies, individuals carrying the MTHFR 677TT variant showed improved blood pressure after riboflavin repletion, suggesting a genotype-specific effect, though responses vary. Separately, trials have found that higher-dose riboflavin reduced migraine attack frequency in some individuals, pointing to a mitochondrial energy angle in the brain. These are targeted findings, not universal outcomes, but they illustrate how a vitamin that powers enzymes can ripple into vascular and neurological health.

It is worth noting what plasma riboflavin does not measure: because plasma levels reflect recent intake rather than tissue stores, a normal plasma result can coexist with cellular insufficiency. Only functional assays like EGRAC reveal whether riboflavin demand at the enzyme level is actually being met.

Interpreting a low, normal, or high riboflavin

Reference intervals are built from population data and tell you what is common, not what is ideal. Interpretation also depends on the test method. Plasma riboflavin swings with recent meals or supplements and can miss a tissue deficit. For the functional EGRAC assay, a coefficient above 1.4 generally suggests insufficiency, while a value at or below 1.2 suggests adequacy — though ranges and cutoffs vary by lab and method. Age, pregnancy, training load, and sample handling (light can degrade riboflavin in the tube) all affect results. A single value is a snapshot; trends and context are the fuller picture.

High riboflavin

High riboflavin in blood or urine usually means a supplement or fortified food was consumed recently. Because B2 is water-soluble, the kidneys clear the excess and urine can turn bright yellow — a common finding, not a toxicity signal. Persistently elevated values without supplementation are uncommon and often reflect timing rather than a biological problem. If an elevated value appears, consider when the last supplement or multivitamin was taken and whether the sample was protected from light. Pairing the result with related markers such as homocysteine, iron status, and other B vitamins helps determine whether this is a one-off timing issue or part of a broader pattern worth confirming on a repeat draw.

Normal riboflavin

A result within the reference range, particularly when confirmed by a functional assay showing an EGRAC at or below 1.2, suggests that riboflavin-dependent enzyme systems are adequately supplied. Even a normal result benefits from context: sample timing, recent dietary changes, and companion markers like homocysteine and B6 help confirm that the methylation and energy pathways are running without a riboflavin bottleneck.

Low riboflavin

Lower-than-expected values can stem from low intake, higher needs, or both. Diets low in dairy, eggs, meats, or fortified grains may fall short if not balanced with plant sources such as mushrooms, legumes, and leafy greens. Pregnancy increases needs. Endurance training and high physical workloads can increase turnover. Alcohol misuse, gastrointestinal conditions, and some medications can impair absorption or metabolism.

Possible signs include cracks at the corners of the mouth (angular cheilitis), a sore or inflamed tongue (glossitis), a scaly rash around the nose or ears, eye fatigue, and low energy or mild anemia on labs. None of these signs are specific to riboflavin deficiency, which is why interpretation relies on patterns across labs and symptoms. If a repeat test still reads low alongside companion clues such as elevated homocysteine or a sluggish B6 activation marker, that points to a meaningful deficit worth discussing with a clinician.

Why riboflavin levels shift so quickly

Several factors can move a riboflavin result independently of true status:

  • Meal and supplement timing: Plasma riboflavin spikes after a supplement or riboflavin-rich meal and clears within hours. A result drawn shortly after intake will read higher than a fasting baseline.
  • Light exposure of the sample: Riboflavin degrades rapidly when exposed to light. A sample not protected immediately after collection can yield a falsely low plasma reading.
  • Pregnancy and lactation: Increased physiological demand raises the threshold for adequacy; the same intake that is sufficient outside pregnancy may be insufficient during it.
  • Alcohol use and gastrointestinal conditions: Heavy alcohol use, inflammatory bowel disease, bariatric surgery, and chronic diarrhea can impair riboflavin absorption or accelerate its loss.
  • B6 activation: Riboflavin is required to convert vitamin B6 into its active coenzyme form (PLP). A low B6 result may therefore reflect upstream riboflavin insufficiency rather than inadequate B6 intake alone.
  • Iron interaction: Riboflavin repletion has been linked to improved iron handling and red blood cell quality in deficient individuals, meaning iron status and riboflavin status can move together.
  • MTHFR genotype: Individuals with the MTHFR 677TT variant may have a higher functional riboflavin requirement because the variant reduces the binding affinity of the enzyme for its FAD cofactor.

Markers that round out a riboflavin reading

Riboflavin rarely tells the whole story in isolation. The following markers provide meaningful context:

  • Homocysteine — riboflavin is a cofactor for MTHFR, the enzyme that recycles homocysteine; elevated homocysteine alongside low or borderline riboflavin (and low B12 or folate) triangulates a one-carbon pathway bottleneck.
  • Vitamin B6 (plasma) — riboflavin is required to activate B6 into its coenzyme form (PLP); a low B6 result may reflect upstream riboflavin insufficiency rather than B6 intake alone.
  • Folate — riboflavin interfaces with folate in the one-carbon and methylation pathway; interpreting either in isolation misses how they interact to keep homocysteine in range.
  • Ferritin — riboflavin repletion has been linked to improved iron handling and red blood cell quality in some deficient individuals; low ferritin alongside low riboflavin may reflect a shared absorption or metabolic bottleneck.
  • Vitamin B12 — B12, B6, and riboflavin are co-participants in the methylation cycle; a full B-vitamin picture is needed to locate which step in the pathway is rate-limiting.

How soon to retest riboflavin after a change

Riboflavin status responds relatively quickly to dietary or supplementation changes. EGRAC — the functional marker — typically normalizes within 4–8 weeks of adequate intake, reflecting enzyme-level repletion. Plasma riboflavin can shift within days, but because it is so sensitive to recent intake and light exposure, it is a less reliable marker for tracking true repletion over time.

A practical retest cadence after a confirmed low result or a change in diet or supplementation is every 3 months until the result is stable and within range. Once replete, riboflavin can be included in a comprehensive panel review once or twice per year.

To standardize results and make comparisons meaningful: draw the sample fasting, in the morning, before any supplements are taken, and ensure the collection tube is protected from light immediately after the draw. When tracking response to an intervention, EGRAC is the preferred retest marker because it reflects functional enzyme-level response rather than recent intake.

When low riboflavin warrants a clinician conversation

A single low or borderline result is a prompt to look more closely, not necessarily to act immediately. The clearest signals that a conversation with a clinician is warranted include: a repeat low result on a fasting, light-protected draw; low riboflavin alongside elevated homocysteine, low B6, or low ferritin; symptoms such as angular cheilitis, glossitis, or unexplained fatigue that align with the lab pattern; or a known risk factor such as pregnancy, heavy alcohol use, a malabsorptive condition, or the MTHFR 677TT genotype.

Testing gives you feedback faster than symptoms do. A trend across a few months — rather than a single measurement — shows whether a change in diet or other factors is moving the needle. That is how prevention works in practice: catch small drifts early, course-correct, and align your biology with how you want to feel and perform. Superpower's approach to preventive health is built on exactly this kind of pattern recognition across a comprehensive biomarker panel, so that riboflavin slots into context alongside energy markers, related B vitamins, iron status, and inflammation signals. Learn more at superpower.com.

Join Superpower today to access advanced biomarker testing with over 100 biomarkers.

```

FAQs

Riboflavin (vitamin B2) is a water-soluble vitamin that the body converts into two coenzymes, FMN and FAD. These coenzymes are required by hundreds of enzymes involved in mitochondrial energy production, fat and carbohydrate metabolism, and antioxidant recycling. Without adequate riboflavin, the cellular machinery for generating ATP and neutralizing oxidative stress runs less efficiently.
Plasma riboflavin levels reflect recent intake and can be elevated by a meal or supplement taken shortly before the draw. Functional assays, particularly the erythrocyte glutathione reductase activation coefficient (EGRAC), are more informative because they measure how well a riboflavin-dependent enzyme performs in red blood cells. Higher activation with added FAD in the assay suggests tissue riboflavin was insufficient.
Interpretation depends on the test used. For EGRAC, an activation coefficient above 1.4 is commonly considered indicative of riboflavin insufficiency, while values at or below 1.2 suggest adequate status. Plasma riboflavin ranges vary widely by lab and intake timing. Reference ranges vary by lab and individual; context including recent diet, supplement use, and light exposure of the sample all affect results.
Low intake from diets sparse in dairy, eggs, meat, and fortified grains is the most common cause. Pregnancy and lactation increase needs significantly. High training volumes, gastrointestinal conditions affecting absorption, heavy alcohol use, and some medications can impair riboflavin status. Because riboflavin activates vitamin B6 and participates in folate metabolism, a deficit can ripple into related pathways.
Symptoms of riboflavin deficiency include cracking at the corners of the mouth (angular cheilitis), a sore red tongue, a scaly rash around the nose and ears, and increased light sensitivity. Fatigue and mild anemia may also appear. None of these signs are specific to riboflavin, so laboratory assessment alongside evaluation of related B vitamins provides the clearest picture.
Research published over the past two decades suggests that high-dose riboflavin (typically 400 mg/day in clinical trials) may reduce migraine attack frequency in some individuals, potentially through a mitochondrial energy mechanism in the brain. Results are not universal. For general energy, riboflavin supports mitochondrial function, but supplementation is most relevant when status is actually low.

References

  1. Wilson, C. P., McNulty, H., Ward, M., Strain, J. J., Trouton, T. G., Hoeft, B. A., Weber, P., Roos, F. F., Horigan, G., McAnena, L., & Scott, J. M. (2013). Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to intervention with riboflavin: findings of a targeted randomized trial. Hypertension, 61(6), 1302-8. https://doi.org/10.1161/HYPERTENSIONAHA.111.01047
  2. Schoenen, J., Jacquy, J., & Lenaerts, M. (1998). Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology, 50(2), 466-70. https://doi.org/10.1212/wnl.50.2.466
  3. Aljaadi, A. M., Devlin, A. M., & Green, T. J. (2022). Riboflavin intake and status and relationship to anemia. Nutrition reviews, 81(1), 114-132. https://doi.org/10.1093/nutrit/nuac043
  4. McNulty, H., Pentieva, K., & Ward, M. (2023). Causes and Clinical Sequelae of Riboflavin Deficiency. Annual review of nutrition, 43, 101-122. https://doi.org/10.1146/annurev-nutr-061121-084407
  5. Duffy, B., McNulty, H., Ward, M., & Pentieva, K. (2026). Anaemia during pregnancy: could riboflavin deficiency be implicated?. The Proceedings of the Nutrition Society, 85(1), 74-81. https://doi.org/10.1017/S0029665124007468

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey